Some allergic reactions in Britain raised concerns, which led Dr. Aleena Banerji, head of the allergy and clinical immunology unit at Massachusetts General Hospital, and her colleagues to review all that’s known about allergic reactions to vaccines.
They offer some advice in a new report, published Dec. 31 in the Journal of Allergy and Clinical Immunology: In Practice, so that people with different allergy histories can safely receive their first COVID-19 vaccine.
They have also developed steps on safely receiving the second dose in those who had a reaction to the first dose of COVID-19 vaccine.
“As allergists, we want to encourage vaccination by reassuring the public that both FDA-approved COVID-19 vaccines are safe,” Banerji said in a hospital news release. “Our guidelines are built upon the recommendations of U.S. regulatory agencies and provide clear steps to the medical community on how to safely administer both doses of the vaccine in individuals with allergic histories.”
Allergic reactions to vaccines are rare, occurring in about 1.3 per 1 million people. The Pfizer-BioNTech and Moderna COVID-19 vaccines will have a similarly low rate, the researchers said.
Also, vaccine clinics will monitor all patients for 15 to 30 minutes and can manage any allergic reactions that occur, they noted.
People with a history of severe allergy (anaphylaxis) to a drug or vaccine should speak with their allergists before being vaccinated. Those with severe allergies to foods, oral drugs, latex or venom can be safely vaccinated, Banerji and her group said.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Further Support and Information on COVID-19
- South African regulator rejects Russia’s COVID-19 vaccine - October 20, 2021
- Second wave of pandemic not receded yet, third wave feared post-Diwali: Maha health minister - October 20, 2021
- WHO chief discusses Covaxin, resumption of AstraZeneca vaccine supplies to COVAX facility with Health Minister Mandaviya - October 20, 2021
- Trivitron Healthcare in collaboration with Diagon- Vanguard Diagnostics launches Diagon’s Coagulation range in India - October 20, 2021
- Breast cancer early detection, screening, and management – what we need to know - October 20, 2021
- WHO’s technical advisory group to meet on Oct 26 to consider Covaxin - October 19, 2021
- 163 oxygen plants set up in MP after shortage during 2nd COVID-19 wave: CM Shivraj Singh Chouhan - October 19, 2021
- India’s R-value below 1 since September, researchers say - October 19, 2021
- Mumbai: Double vaccine jab not mandatory to enter theatres, colleges to reopen with 50% attendance - October 19, 2021
- Daily exercise routine, balanced diet, active lifestyle & quality sleep key to success in personal & professional lives: Experts - October 19, 2021